|
2024 Conference Publication Environmentally stressed drug-naive melanoma cell subpopulations share a molecular signature with drug-induced early persister cellsKangachar, S. Asgharzadeh, Ahmed, F., Al Emran, A., Boyle, G., Spoerri, L., Schaider, H. and Haass, N. K. (2024). Environmentally stressed drug-naive melanoma cell subpopulations share a molecular signature with drug-induced early persister cells. Society for Investigative Dermatology (SID) 2024 Meeting, Dallas, TX, United States, 15-18 May 2024. Oxford, United Kingdom: Elsevier. |
|
2024 Conference Publication Environmentally stressed drug-naïve melanoma cell subpopulations share a molecular signature with drug-induced early persister cellsKangachar, S. Asgharzadeh, Ahmed, F., Al Emran, A., Boyle, G., Spoerri, L., Schaider, H. and Haass, N.K. (2024). Environmentally stressed drug-naïve melanoma cell subpopulations share a molecular signature with drug-induced early persister cells. Society for Investigative Dermatology (SID) 2024 Meeting, Dallas, TX United States, 15-18 May 2024. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2024.06.641 |
|
2024 Conference Publication A calcium influx pathway regulates adaptive melanoma drug toleranceGuan, Yimeng, Robitaille, Melanie, Torrano, Joachim, Haass, Nikolas, Roberts-Thomson, Sarah, Monteith, Gregory and Schaider, Helmut (2024). A calcium influx pathway regulates adaptive melanoma drug tolerance. ASDR 2024 Annual Scientific Meeting, Sydney, NSW Australia, 18-20 July 2024. |
|
2024 Conference Publication Exploring calcium signalling remodelling during adaptive cancer drug toleranceRobitaille, Melanie, Schaider, Helmut, Monteith, Gregory and Roberts-Thomson, Sarah (2024). Exploring calcium signalling remodelling during adaptive cancer drug tolerance. Calcium Signaling- Gordon Research Conference, Barga, Lucca, Italy, 30 June - 5 July 2024. |
|
2024 Conference Publication O-GlcNAc transferase drives the proliferative state in adaptive drug toleranceMenon, Dinoop Ravindran, Hammerlindl, Heinz, Gimenez, Gregory, Zuegner, Elmar, Magens, Christoph, Eccles, Michael, Fujita, Mayumi and Schaider, Helmut (2024). O-GlcNAc transferase drives the proliferative state in adaptive drug tolerance. AACR Annual Meeting 2024, San Diego, CA United States, 5-10 April 2024. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.am2024-lb293 |
|
2023 Conference Publication Exploring calcium signalling remodelling during adaptive cancer drug toleranceRobitaille, Mélanie, Schaider, Helmut, Roberts-Thomson, Sarah and Monteith, Gregory (2023). Exploring calcium signalling remodelling during adaptive cancer drug tolerance. ASCEPT Annual Scientific Meeting, Sydney, NSW Australia, 20-23 November 2023. |
|
2023 Conference Publication High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC studyLadwa, R., Monkman, J., Sadeghirad, H., Cooper, C., Belz, G., Bowman, J., Schaider, H., Liu, H., Kulasinghe, A. and Porceddu, S. (2023). High-plex spatial profiling of cutaneous squamous cell carcinoma to identify biomarkers associated with clinical outcomes: The cMIC study. ESMO Congress 2023, Madrid, Spain, 20-24 October 2023. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.annonc.2023.09.2278 |
|
2023 Conference Publication Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipientsCox, Charlotte, Lee, Ruby, Liyanage, Upekha, Brown, Susan, Isbel, Nicole, Chambers, Daniel, Griffin, Anthony, Campbell, Scott, Hopkins, Peter, Schaider, Helmut, Soyer, Peter and Khosrotehrani, Kiarash (2023). Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients. HOBOKEN: WILEY. |
|
2023 Conference Publication 1244 Epigenetic and metabolic vulnerabilities of adaptive drug resistance to targeted therapies in melanomaTorrano, J., Ravindran-Menon, D., Hammerlindl, H., Hammerlindl, S., Emran, A.A., Bordag, N., Zuegner, E., Haass, N.K., Sadowski, M., Stow, J., Magnes, C., Fujita, M. and Schaider, H. (2023). 1244 Epigenetic and metabolic vulnerabilities of adaptive drug resistance to targeted therapies in melanoma. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10-13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1258 |
|
2023 Conference Publication Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent neviMuse, Meghan E., Schaider, Helmut, Oey, Harald, Soyer, H. Peter, Christensen, Brock C. and Stark, Mitchell S. (2023). Distinct HOX gene family DNA methylation profiles in histologically normal skin dependent on dermoscopic pattern of adjacent nevi. 114th Annual Meeting of the American Association for Cancer Research (AACR), Orlando Fl, Apr 14-19, 2023. PHILADELPHIA: AMER ASSOC CANCER RESEARCH. doi: 10.1158/1538-7445.AM2023-6000 |
|
2023 Conference Publication MITF-mediated changes of tumour architecture, tensile stress and in extracellular matrix (ECM) control intratumour heterogeneity in melanomaSpoerri, L., Tonnessen-Murray, C. A., Beaumont, K. A., Hill, D. S., Jurek, R. J., Gunasingh, G., Vanwalleghem, G., Daignault, S., Fane, M. E., Schaider, H., Smith, A., Stehbens, S. J., Weninger, W., Scott, E. E., Gabrielli, B. and Haass, N. (2023). MITF-mediated changes of tumour architecture, tensile stress and in extracellular matrix (ECM) control intratumour heterogeneity in melanoma. Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Berlin, Germany, 11-14 March 2020. Chichester, West Sussex United Kingdom: Wiley-Blackwell. |
|
2021 Conference Publication Preclinical study of aspirin and regorafenib combination therapy for colorectal cancerSu, C., Bond, C., Fennell, L., Kerr, G., Jarde, T., Micati, D., Engel, R., Chan, W. H., Hlavca, S., Archer, S., Mcmurrick, P., Hammerlindl, H., Lim, F., Salik, B., Mckeone, D., Hartel, G., Leggett, B., Schaider, H., Abud, H., Boyle, G., Burge, M. and Whitehall, V. (2021). Preclinical study of aspirin and regorafenib combination therapy for colorectal cancer. GESA AGW 2021, Online, 4 - 12 September 2021. HOBOKEN: WILEY. |
|
2019 Conference Publication Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanomaFaleiro, Rebecca J., Karunarathne, Deshapriya S., Liu, Ji, Boyle, Glen, Hartel, Gunter, Hayward, Nick, Schaider, Helmut, Waddell, Nic, Schmidt, Chris and Wykes, Michelle (2019). Programmed death-1 ligand 2 (PD-L2) on dendritic cells protects T cells from cellular exhaustion during melanoma. Annual Meeting of the American Association for Cancer Research (AACR), Atlanta, GA, United States, 29 March - 3 April, 2019. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.SABCS18-4112 |
|
2019 Conference Publication Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanomaSpoerri, L., Tonnessen, C. A., Beaumont, K. A., Hill, D. S., Jurek, R. J., Smith, A., Scott, E., Schaider, H., Gabrielli, B., Weninger, W. and Haass, N. (2019). Microphthalmia-associated transcription factor regulates dynamic heterogeneity and structural integrity in melanoma. 46th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Munich, Germany, 13-16 March, 2019. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.13859 |
|
2019 Conference Publication ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care settingEconomides, A., Mar, V., Soyer, H. P., Schaider, H., Sadeghi, M. and Guitera, P. (2019). ANZMTG NRP 09.18 alert - Assessing teledermatology referral for managing patients in the primary care setting. 2019 Dermcoll, Melbourne, Australia, 18 – 21 May 2019. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2018 Conference Publication Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanomaMenon, D. Ravindran, Hammerlindl, H., Emran, A., Torrano, J., Hammerlindl, S., Zhang, G., Krause, L., Somasundaram, R., Sturm, R., Haass, N. K., Flaherty, K., Herlyn, M. and Schaider, H. (2018). Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanoma. International Investigative Dermatology (IID) Meeting, Orlando, Fl, United States, 16-19 May 2018. London, United Kingdom: Nature Publishing Group. doi: 10.1016/j.jid.2018.03.1252 |
|
2018 Conference Publication Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanomaEmran, A., Chowdhury, B. R., Hammerlindl, H., Ahmed, F., Haass, N. K., Schuehly, W. and Schaider, H. (2018). Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 19-22 May 2018. Hoboken, NJ, United States: Wiley. |
|
2018 Conference Publication Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphomaSchukoff, T., Winkler, S., Unterluggauer, J. J., Fechter, K., Greinix, H., Beham-Schmid, C., Schaider, H., Deutsch, A., Prochazka, K. and Neumeister, P. (2018). Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma. Unknown, Unknown, Unknown. Basel, Switzerland: S. Karger AG. |
|
2018 Conference Publication Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasmsStark, Mitchell S., Tan, Jean-Marie, Tom, Lisa, Jagirdar, Kasturee, Lambie, Duncan, Schaider, Helmut, Soyer, H. Peter and Sturm, Richard A. (2018). Whole-exome sequencing of acquired nevi identifies novel mechanisms for development and maintenance of benign neoplasms. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, Illinois, 14-18 April 2018. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2018-5376 |
|
2018 Conference Publication Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi resistant melanomaMenon, Dinoop Ravindran, Hammerlindl, Heinz, Al Emran, Abdullah, Torrano, Joachim, Hammerlindl, Sabrina, Zhang, Gao, Somasundaram, Rajasekharan, Sturm, Richard A., Haass, Nikolas K., Flaherty, Keith, Herlyn, Meenhard and Schaider, Helmut (2018). Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi resistant melanoma. Annual Meeting of the American Association for Cancer Research (AACR), Chicago, IL United States, 14-18 April 2018. Philadelphia, PA United States: American Association of Cancer Research. doi: 10.1158/1538-7445.AM2018-5833 |
